EQUASENS (EQS.PA) Stock Fundamental Analysis
EPA:EQS - Euronext Paris - Matif - FR0012882389 - Common Stock - Currency: EUR
Taking everything into account, EQS scores 6 out of 10 in our fundamental rating. EQS was compared to 11 industry peers in the Health Care Technology industry. EQS has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. EQS is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year EQS was profitable.
In the past year EQS had a positive cash flow from operations.
Each year in the past 5 years EQS has been profitable.
Each year in the past 5 years EQS had a positive operating cash flow.
1.2 Ratios
The Return On Assets of EQS (9.10%) is better than 81.82% of its industry peers.
EQS has a better Return On Equity (15.65%) than 90.91% of its industry peers.
With an excellent Return On Invested Capital value of 12.02%, EQS belongs to the best of the industry, outperforming 90.91% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for EQS is significantly above the industry average of 7.26%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.1% | ||
| ROE | 15.65% | ||
| ROIC | 12.02% |
ROA(3y)11.42%
ROA(5y)11.3%
ROE(3y)20.52%
ROE(5y)21.51%
ROIC(3y)15.18%
ROIC(5y)16.08%
1.3 Margins
EQS's Profit Margin of 16.72% is amongst the best of the industry. EQS outperforms 90.91% of its industry peers.
EQS's Profit Margin has been stable in the last couple of years.
EQS has a Operating Margin of 20.18%. This is amongst the best in the industry. EQS outperforms 100.00% of its industry peers.
EQS's Operating Margin has declined in the last couple of years.
The Gross Margin of EQS (68.77%) is worse than 63.64% of its industry peers.
In the last couple of years the Gross Margin of EQS has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 20.18% | ||
| PM (TTM) | 16.72% | ||
| GM | 68.77% |
OM growth 3Y-8.16%
OM growth 5Y-4.74%
PM growth 3Y-6.19%
PM growth 5Y-1.37%
GM growth 3Y-0.25%
GM growth 5Y0.16%
2. Health
2.1 Basic Checks
EQS has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, EQS has about the same amount of shares outstanding.
Compared to 5 years ago, EQS has more shares outstanding
EQS has a better debt/assets ratio than last year.
2.2 Solvency
EQS has an Altman-Z score of 4.62. This indicates that EQS is financially healthy and has little risk of bankruptcy at the moment.
EQS has a Altman-Z score of 4.62. This is amongst the best in the industry. EQS outperforms 90.91% of its industry peers.
EQS has a debt to FCF ratio of 1.29. This is a very positive value and a sign of high solvency as it would only need 1.29 years to pay back of all of its debts.
The Debt to FCF ratio of EQS (1.29) is better than 72.73% of its industry peers.
A Debt/Equity ratio of 0.12 indicates that EQS is not too dependend on debt financing.
EQS's Debt to Equity ratio of 0.12 is fine compared to the rest of the industry. EQS outperforms 72.73% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.12 | ||
| Debt/FCF | 1.29 | ||
| Altman-Z | 4.62 |
ROIC/WACC1.57
WACC7.67%
2.3 Liquidity
A Current Ratio of 1.21 indicates that EQS should not have too much problems paying its short term obligations.
The Current ratio of EQS (1.21) is comparable to the rest of the industry.
EQS has a Quick Ratio of 1.10. This is a normal value and indicates that EQS is financially healthy and should not expect problems in meeting its short term obligations.
EQS has a Quick ratio (1.10) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.21 | ||
| Quick Ratio | 1.1 |
3. Growth
3.1 Past
EQS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -23.02%.
Measured over the past 5 years, EQS shows a small growth in Earnings Per Share. The EPS has been growing by 5.12% on average per year.
Looking at the last year, EQS shows a decrease in Revenue. The Revenue has decreased by -1.37% in the last year.
Measured over the past years, EQS shows a small growth in Revenue. The Revenue has been growing by 6.45% on average per year.
EPS 1Y (TTM)-23.02%
EPS 3Y-2.55%
EPS 5Y5.12%
EPS Q2Q%-24.02%
Revenue 1Y (TTM)-1.37%
Revenue growth 3Y3.93%
Revenue growth 5Y6.45%
Sales Q2Q%1.49%
3.2 Future
The Earnings Per Share is expected to grow by 18.54% on average over the next years. This is quite good.
EQS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.74% yearly.
EPS Next Y27.31%
EPS Next 2Y18.54%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year9.26%
Revenue Next 2Y11.8%
Revenue Next 3Y9.29%
Revenue Next 5Y7.74%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 21.28, which indicates a rather expensive current valuation of EQS.
90.91% of the companies in the same industry are more expensive than EQS, based on the Price/Earnings ratio.
EQS's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 26.35.
EQS is valuated rather expensively with a Price/Forward Earnings ratio of 17.42.
63.64% of the companies in the same industry are more expensive than EQS, based on the Price/Forward Earnings ratio.
EQS is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.20, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.28 | ||
| Fwd PE | 17.42 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as EQS.
63.64% of the companies in the same industry are more expensive than EQS, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 21.48 | ||
| EV/EBITDA | 12.79 |
4.3 Compensation for Growth
EQS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
EQS has a very decent profitability rating, which may justify a higher PE ratio.
EQS's earnings are expected to grow with 18.54% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.78
PEG (5Y)4.15
EPS Next 2Y18.54%
EPS Next 3YN/A
5. Dividend
5.1 Amount
EQS has a Yearly Dividend Yield of 2.46%.
EQS's Dividend Yield is a higher than the industry average which is at 3.69.
EQS's Dividend Yield is comparable with the S&P500 average which is at 2.40.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.46% |
5.2 History
On average, the dividend of EQS grows each year by 8.00%, which is quite nice.
Dividend Growth(5Y)8%
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
51.86% of the earnings are spent on dividend by EQS. This is a bit on the high side, but may be sustainable.
EQS's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP51.86%
EPS Next 2Y18.54%
EPS Next 3YN/A
EPA:EQS (5/28/2025, 9:33:31 AM)
50.85
-0.55 (-1.07%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners13.44%
Inst Owner ChangeN/A
Ins Owners0.2%
Ins Owner ChangeN/A
Market Cap771.39M
Analysts76.67
Price Target60.69 (19.35%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.46% |
Yearly Dividend1.25
Dividend Growth(5Y)8%
DP51.86%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-14.57%
PT rev (3m)-14.57%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-2.36%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.28 | ||
| Fwd PE | 17.42 | ||
| P/S | 3.56 | ||
| P/FCF | 21.48 | ||
| P/OCF | 16.22 | ||
| P/B | 3.33 | ||
| P/tB | 9.46 | ||
| EV/EBITDA | 12.79 |
EPS(TTM)2.39
EY4.7%
EPS(NY)2.92
Fwd EY5.74%
FCF(TTM)2.37
FCFY4.66%
OCF(TTM)3.13
OCFY6.16%
SpS14.29
BVpS15.26
TBVpS5.38
PEG (NY)0.78
PEG (5Y)4.15
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.1% | ||
| ROE | 15.65% | ||
| ROCE | 14.76% | ||
| ROIC | 12.02% | ||
| ROICexc | 14.31% | ||
| ROICexgc | 35.95% | ||
| OM | 20.18% | ||
| PM (TTM) | 16.72% | ||
| GM | 68.77% | ||
| FCFM | 16.57% |
ROA(3y)11.42%
ROA(5y)11.3%
ROE(3y)20.52%
ROE(5y)21.51%
ROIC(3y)15.18%
ROIC(5y)16.08%
ROICexc(3y)19.36%
ROICexc(5y)21.38%
ROICexgc(3y)50.59%
ROICexgc(5y)62.81%
ROCE(3y)18.64%
ROCE(5y)19.75%
ROICexcg growth 3Y-25.09%
ROICexcg growth 5Y-9.54%
ROICexc growth 3Y-15.77%
ROICexc growth 5Y-10.18%
OM growth 3Y-8.16%
OM growth 5Y-4.74%
PM growth 3Y-6.19%
PM growth 5Y-1.37%
GM growth 3Y-0.25%
GM growth 5Y0.16%
F-Score5
Asset Turnover0.54
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.12 | ||
| Debt/FCF | 1.29 | ||
| Debt/EBITDA | 0.48 | ||
| Cap/Depr | 79.39% | ||
| Cap/Sales | 5.37% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 81.41% | ||
| Profit Quality | 99.11% | ||
| Current Ratio | 1.21 | ||
| Quick Ratio | 1.1 | ||
| Altman-Z | 4.62 |
F-Score5
WACC7.67%
ROIC/WACC1.57
Cap/Depr(3y)96.13%
Cap/Depr(5y)118.08%
Cap/Sales(3y)6.18%
Cap/Sales(5y)7.08%
Profit Quality(3y)94.47%
Profit Quality(5y)93.6%
High Growth Momentum
Growth
EPS 1Y (TTM)-23.02%
EPS 3Y-2.55%
EPS 5Y5.12%
EPS Q2Q%-24.02%
EPS Next Y27.31%
EPS Next 2Y18.54%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-1.37%
Revenue growth 3Y3.93%
Revenue growth 5Y6.45%
Sales Q2Q%1.49%
Revenue Next Year9.26%
Revenue Next 2Y11.8%
Revenue Next 3Y9.29%
Revenue Next 5Y7.74%
EBIT growth 1Y-20.84%
EBIT growth 3Y-4.55%
EBIT growth 5Y1.4%
EBIT Next Year71.53%
EBIT Next 3Y25.63%
EBIT Next 5YN/A
FCF growth 1Y-8.64%
FCF growth 3Y-1.08%
FCF growth 5Y8.7%
OCF growth 1Y-17.61%
OCF growth 3Y0.02%
OCF growth 5Y3.18%